PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsBretylium
Bretylium
Bretylol (bretylium) is a small molecule pharmaceutical. Bretylium was first approved as Bretylol on 1982-01-01. It is used to treat ventricular fibrillation and ventricular tachycardia in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bretylium tosylate
Tradename
Company
Number
Date
Products
BRETYLIUM TOSYLATE IN DEXTROSE 5%Abbott BiotherapeuticsN-019005 DISCN1986-04-29
3 products
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERB. Braun MedicalN-019121 DISCN1986-04-29
3 products
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERBaxterN-019837 DISCN1989-04-12
2 products
BRETYLOLHospiraN-017954 DISCN1982-01-01
1 products
BRETYLIUM TOSYLATEHospiraN-019030 DISCN1986-04-29
1 products, RLD
BRETYLIUM TOSYLATEHospiraN-019033 DISCN1986-04-29
1 products
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERHospiraN-019008 DISCN1986-04-29
3 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
ventricular fibrillationEFO_0004287D014693I49.01
ventricular tachycardia—D017180I47.2
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
— C01: Cardiac therapy drugs
— C01B: Antiarrhythmics, class i and iii
— C01BD: Antiarrhythmics, class iii
— C01BD02: Bretylium tosilate
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameBretylium
INNbretylium tosilate
Description
Bretylium is a quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. It has a role as an adrenergic antagonist, an anti-arrhythmia drug and an antihypertensive agent.
Classification
Small molecule
Drug classquaternary ammonium derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC[N+](C)(C)Cc1ccccc1Br
Identifiers
PDB—
CAS-ID59-41-6
RxCUI—
ChEMBL IDCHEMBL1199080
ChEBI ID3172
PubChem CID2431
DrugBankDB01158
UNII ID78ZP3YR353 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,218 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use